#USA #Luxembourg #dBio #Nike #Bert Hoyt

Bert Hoyt Joins dBio: A New Era in Sports and Health Technology

In a significant move for the sports and health technology sector, Decentralized Biotechnology Intelligence Holding Group Inc. (dBio) has appointed Bert Hoyt as a board advisor. Hoyt, a distinguished figure in the sports industry with over 30 years of experience, has held high-ranking positions at leading brands like Puma and Nike. His expertise will be instrumental in advancing dBio’s mission of revolutionizing personalized health and fitness technologies.

A Visionary Leader

Bert Hoyt's illustrious career began in 1989 at Puma, where he played critical roles that shaped the brand’s commercial direction. His tenure at Puma culminated in his leadership as the General Manager of Puma International, during which the company saw remarkable growth from 1992 to 1998. Following his impactful years at Puma, Hoyt spent more than two decades at Nike in various leadership roles, including nine years as the Vice President and General Manager for Nike Western Europe and the EMOA regions, where he crafted strategies that led to unprecedented market domination.

Hoyt's deep understanding of consumer needs and his capacity to align teams with a compelling vision have been pivotal in growing Nike's revenue in the region from $3 billion to $7 billion, significantly impacting the company's overall profitability.

Innovations in Health and Performance

As an advisor at dBio, Hoyt will leverage his extensive background to contribute to the company's innovative solutions that merge athlete performance with real-time health insights. dBio specializes in advanced AIoT wearable devices, designed not just for elite athletes but also for fitness enthusiasts. Their flagship products, such as the gMOTCloud—a cutting-edge kinesiology wearable that captures detailed movement metrics—promise to optimize athletic performance and reduce injury risks.

Another groundbreaking product from dBio, StethoCloud, a lightweight portable stethoscope, brings continuous heart and respiratory monitoring to the forefront, enhanced by AI technology for noise reduction. Together, these tools form a comprehensive data-driven ecosystem aimed at providing personalized feedback, thus empowering users to enhance their training regimens and overall well-being.

With more than 75 patents and a fully developed ecosystem covering AI modeling, hardware, software, and application development, dBio is well poised to redefine the future of personalized health and performance enhancement. Their strategic partnerships in the medical, academic, and sports sectors further bolster their innovative aspirations.

Hoyt’s Commitment to Athlete Wellness

Hoyt's decision to join dBio as an advisor stems from his profound passion for athlete enhancement. He believes that dBio's tools can unlock new pathways for improving athletic performance and enhancing general wellness for sports enthusiasts. He stated, “Throughout my personal and professional journey, I have strived to help athletes enhance their performance and overall well-being. Joining dBio as an advisor aligns perfectly with my commitment to driving innovations that will elevate athletic performance and provide essential data for managing well-being.”

As dBio expands its global footprint, the company is set to redefine how personalized health care and performance technology are intertwined. The addition of Bert Hoyt to the advisory board not only enhances the strategic direction of the company but also promises exciting developments in the landscape of sports health technology.